Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Guardant Health ( (GH) ) has shared an announcement.
Guardant Health, Inc. announced it will host an Investor Day on September 24, 2025, in New York City, featuring presentations from its co-CEOs and executive team to discuss the company’s operations, strategic priorities, and financial outlook. This event is expected to provide stakeholders with valuable insights into the company’s future direction and market positioning.
The most recent analyst rating on (GH) stock is a Buy with a $60.00 price target. To see the full list of analyst forecasts on Guardant Health stock, see the GH Stock Forecast page.
Spark’s Take on GH Stock
According to Spark, TipRanks’ AI Analyst, GH is a Neutral.
Guardant Health’s overall stock score is driven by strong technical indicators and a positive earnings call, which highlight significant revenue growth and improved margins. However, financial performance and valuation concerns due to ongoing losses and negative equity weigh down the score.
To see Spark’s full report on GH stock, click here.
More about Guardant Health
Guardant Health, Inc. operates in the healthcare industry, focusing on developing blood tests for cancer detection and treatment guidance.
Average Trading Volume: 2,536,614
Technical Sentiment Signal: Buy
Current Market Cap: $7.19B
Find detailed analytics on GH stock on TipRanks’ Stock Analysis page.